Search

Your search keyword '"Hilbrands, Luuk B."' showing total 727 results

Search Constraints

Start Over You searched for: Author "Hilbrands, Luuk B." Remove constraint Author: "Hilbrands, Luuk B."
727 results on '"Hilbrands, Luuk B."'

Search Results

1. Revealing the significance of IL-2 and IL-5 in SARS-CoV-2-specific T-cell responses in kidney transplant recipients

2. Trained immunity is regulated by T cell-induced CD40-TRAF6 signaling

3. Trained immunity suppression determines kidney allograft survival

4. Association of obesity with 3-month mortality in kidney failure patients with COVID-19.

5. Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA

6. Clinical, Functional, and Mental Health Outcomes in Kidney Transplant Recipients 3 Months After a Diagnosis of COVID-19

7. Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease: A nested case-control study

8. Th1-dominant cytokine responses in kidney patients after COVID-19 vaccination are associated with poor humoral responses

10. Acid ceramidase regulates innate immune memory

14. The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients

15. Adherence to preventive measures after SARS-CoV-2 vaccination and after awareness of antibody response in kidney transplant recipients in the Netherlands: a nationwide questionnaire study

17. Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial

22. Isavuconazole as prophylaxis and therapy for invasive fungal diseases: a real-life observational study.

23. The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment

25. SARS-CoV-2 Spike-specific IFN-γ T-cell Response After COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant

29. Ellipro scores of donor epitope specific HLA antibodies are not associated with kidney graft survival

30. Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients

31. Determination of the clinical relevance of donor epitope-specific HLA-antibodies in kidney transplantation

32. Primary Exposure to SARS-CoV-2 via Infection or Vaccination Determines Mucosal Antibody-Dependent ACE2 Binding Inhibition

33. Ellipro scores of donor epitope specific HLA antibodies are not associated with kidney graft survival

34. Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease:A nested case-control study

35. Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons

36. The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant

37. Determination of the clinical relevance of donor epitope‐specific HLA‐antibodies in kidney transplantation

38. Antibodies against ARHGDIB are associated with long-term kidney graft loss

40. Primary Exposure to SARS-CoV-2 via Infection or Vaccination Determines Mucosal Antibody-Dependent ACE2 Binding Inhibition

42. The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients

44. Adherence to preventive measures after SARS-CoV-2 vaccination and after awareness of antibody response in kidney transplant recipients in the Netherlands: a nationwide questionnaire study

45. Strategies to prevent SARS-CoV-2 transmission in hemodialysis centres across Europe—lessons for the future

46. Ellipro scores of donor epitope specific HLA antibodies are not associated with kidney graft survival.

48. The Role of Interleukin-21 in COVID-19 Vaccine-Induced B Cell-Mediated Immune Responses in Kidney Disease Patients and Kidney Transplant Recipients

50. Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial

Catalog

Books, media, physical & digital resources